18 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
for a Three-Year Term Expiring at the 2026 Annual Meeting
INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
Independence Of The Board … Of The Board Of Directors
Audit Committee
Compensation Committee
Nominating and Corporate Governance Committee
Stockholder Communications With The Board
8-K
EX-99.1
v7wgi11xmxaz3g1 v5s9
14 Nov 22
Acumen Pharmaceuticals Reports Third Quarter 2022
4:10pm
DEF 14A
zpwk7gd
27 Apr 22
Definitive proxy
5:03pm
10-K
ty5rzlstkf
28 Mar 22
Annual report
4:51pm
10-K
EX-10.3
k3zsq1ll
28 Mar 22
Annual report
4:51pm
10-Q
pc1 03851dfgm40ur11
16 Aug 21
Quarterly report
4:51pm
424B4
n3ruowu37u ojfe
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
1tfbjq0x
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.2
hzmqijdobqgiya
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.3
sdyo81e
24 Jun 21
IPO registration (amended)
8:17am
S-1
in0yh uf1xv
9 Jun 21
IPO registration
5:02pm
DRS/A
536frc
14 May 21
Draft registration statement (amended)
12:00am
DRS
a9zfty th3qjfmwvv7
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next